Certara stock.

54.33%. Get the latest Certara Inc (CERT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment …OPKO Health Inc. 1.53. +0.07. +4.79%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.The estimated Net Worth of William F Feehery is at least $75.5 million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $42,281,189 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Certara, Inc. (NASDAQ:CERT – Get Free Report) was the target of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 4,690,000 shares, a ...The high in the last 52 weeks of Certara stock was 24.95. According to the current price, Certara is 58.68% away from the 52-week high. What are analysts …

Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensThe estimated Net Worth of William F Feehery is at least $74.9 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $41,776,274 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.

Nov 27, 2022 · ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ... Nov 27, 2022 · ClearBridge Investments highlighted stocks like Certara, Inc. (NASDAQ: CERT) in its Q3 2022 investor letter. Headquartered in Princeton, New Jersey, Certara, Inc. (NASDAQ:CERT) is a software ...

The estimated net worth of Robert Aspbury is at least $5.51 million as of June 14th, 2021. Dr. Aspbury owns 375,451 shares of Certara stock worth more than $5,511,621 as of November 28th. This net worth estimate does not reflect any other investments that Dr. Aspbury may own.11 Okt 2023 ... 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial ...Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ...Commit To Buy Certara At $12.50, Earn 14.4% Annualized Using Options Stock Options Channel Staff - Friday, November 17, 2:05 PM. Investors considering a purchase of Certara Inc stock, but cautious about paying the going market price of $14.65/share, might benefit from considering selling puts among the alternative …

Insiders trading at Certara. Over the last 4 years, insiders at Certara have traded over $2,047,095,989 worth of Certara stock and bought 97,245 units worth $1,908,085 . The most active insiders traders include Avatar Parent L.P.Eqt Avata..., James E Iii Cashman, and Mason P Slaine.On average, Certara executives and independent …

Oct 11, 2023 · PRINCETON, N.J, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2023 after the market close on Wednesday November 8 th , 2023.

Certara, Inc. (CERT) delivered earnings and revenue surprises of 14.29% and 4.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Why Certara. Responsibility. Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. Locations. Discover our global office locations. LeadershipCommit To Buy Certara At $12.50, Earn 14.4% Annualized Using Options Stock Options Channel Staff - Friday, November 17, 2:05 PM. Investors considering a purchase of Certara Inc stock, but cautious about paying the going market price of $14.65/share, might benefit from considering selling puts among the alternative …Find the latest Oshkosh Corporation (OSK) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest information on Certara, Inc. (CERT) stock, including its performance, outlook, earnings, dividends, and insider transactions. See how CERT stock compares to other medical AI companies and the healthcare industry. What is the support and resistance for Certara (CERT) stock price? CERT support price is $14.50 and resistance is $15.44 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CERT stock …

1.34%. $25.98M. Plains All American Pipeline L.P. 1.86%. $10.93B. TELL | Complete Tellurian Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Certara Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate ...Nov 11, 2022 · Certara ( CERT -1.83%), which provides software and technology to help pharmaceutical companies and researchers accelerate drug development, saw its shares rise 37.7% this week. The stock closed ... Aug 12, 2022 · Certara became a member of the Nasdaq after an upsized initial public offering of its 29,055,000 shares of Class A common stock at $23 per share. Through the IPO, the company raised $316.3 million ... Certara, Inc. Common Stock (CERT) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time Live After-Hours Charts Key Data Bid Price and Ask Price The bid & ask refers to the price that... 21 Seconds 22 -40% on all our subscriptions* Exceptional extension! Enjoy this offer * See conditions on site Financials (USD) More Fundamentals * Assessed data …

Mar 10, 2023 · Certara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%.

Why Certara. Responsibility. Certara is committed to understanding, monitoring, and managing our social and environmental responsibilities. Regulatory Adoption. Many global regulatory agencies have adopted use of Certara’s Simcyp PBPK and Phoenix PK/PD platforms. Locations. Discover our global office locations. LeadershipCertara Inc’s stock is NA in 2023, NA in the previous five trading days and up 17.38% in the past year. Currently, Certara Inc’s price-earnings ratio is 112.4. Certara Inc’s trailing 12-month revenue is $352.1 million with a 5.4% net profit margin. Year-over-year quarterly sales growth most recently was 9.3%.Dr Feehery owns over 36,580 units of Certara stock worth over $42,522,670 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara. Wallmine is a …9 Nov 2023 ... Certara, Inc. (CERT) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate.Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?In other Certara news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction dated Monday, September 11th. The stock was sold at an average price of $14.60, for a total transaction of $747,870.40. Following the transaction, the insider now directly owns 128,883 shares in the company, valued at $1,881,691.80.Certara stock ( CERT) appears to check all the boxes. Nominated by one of our lovely subscribers, the New Jerzee-based company serves the drug development industry by offering software and services around its biosimulation platform. It claims to compete indirectly with companies like Schrödinger ( SDGR ), which uses a …View the latest Certara Inc. (CERT) stock price, news, historical charts, analyst ratings and financial information from WSJ. 1.53. +0.02. +1.66%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Dec 1, 2023 · Latest Software and Docebo Inc, Certara Inc Stock News. As of December 1, 2023, Docebo Inc had a $1.9 billion market capitalization, compared to the Software median of $398.3 million. Docebo Inc’s stock is NA in 2023, NA in the previous five trading days and up 41.82% in the past year. Currently, Docebo Inc does not have a price-earnings ratio.

... stock price by the number of shares outstanding. Certara market cap as of December 01, 2023 is $2.34B. Compare CERT With Other Stocks. Sector, Industry, Market ...

Certara (CERT) stock rose ~15% on Thursday after Q4 results beat estimates and the company's FY23 outlook range surpassed analysts expectations.Adjusted EPS grew +166.6% Y/Y to $0.16,...

Dec 1, 2023 · Certara, Inc. (CERT) is a biosimulation software company that provides products and services for drug discovery and development. The stock price, quote, news, and analysis of CERT are updated daily on this web page. See the latest financial performance, earnings, dividends, and ratings of CERT. 1.53. +0.02. +1.66%. Get Certara Inc (CERT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Arsenal will acquire approximately 30M shares at $15 per share from funds controlled by EQT Private Equity and agrees to two-year lock-up on sale of shares. PRINCETON, N.J.— November 7, 2022 — Certara, Inc. (Nasdaq: CERT) today announced that Arsenal Capital Partners (“Arsenal”), a private equity firm specializing in investing in and building transformational healthcare companies, has ...Download Version 8.4. Reach Your Professional Development Goals. Certara University provides on-demand and on-site courses. Our programs are designed for novice and advanced users in the area of pharmacokinetic (PK) and pharmacodynamics (PD) and are taught using Certara software including the industry-standard software Phoenix …The estimated Net Worth of William F Feehery is at least $74.9 Million dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $41,776,274 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Here are three high-yield tech stocks worth considering right now. With its stock down around 10% over the past year and a dividend yielding 3.4% annually as of this writing, semiconductor giant ...Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.Find real-time CERT - Certara Inc stock quotes, company profile, news and forecasts from CNN Business. Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will explore the best sources for high-quality really free stock ph...Josh Xie is Director-Clinical Pharmacology at Certara, Inc. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Stock markets for all 100% Free Registration. 100% Free Registration10 Des 2020 ... (Reuters) -U.S. drug development consultancy Certara Inc said on Thursday it sold shares in its initial public offering at $23 apiece, ...

Certara, Inc. is a provider of biosimulation software and technology-enabled services. The Company is focused on producing medicines for patients using biosimulation software, technology, and services to transform traditional drug discovery and development.PRINCETON, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share.1.34%. $25.98M. Plains All American Pipeline L.P. 1.86%. $10.93B. TELL | Complete Tellurian Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Instagram:https://instagram. goog stock price predictionquarter from 1776 to 1976 worthwhat company makes modelo beerbest liability insurance for nurses The average twelve-month price prediction for Air Products and Chemicals is $320.31 with a high price target of $360.00 and a low price target of $240.00. Learn more on APD's analyst rating history. Do Wall Street analysts like Air Products and Chemicals more than its competitors? american weed companiesseven oaks capital Mar 10, 2023 · Certara Inc’s (CERT) price is currently up 7.73% so far this month. During the month of March, Certara Inc’s stock price has reached a high of $22.02 and a low of $18.20. Over the last year, Certara Inc has hit prices as high as $24.66 and as low as $10.60. Year to date, Certara Inc’s stock is down 31.32%. The new Simcyp Discovery Simulator is an intuitive PBPK software that delivers confidence in decision-making during the pre-Investigational New Drug (IND) Application and translational stages. Derived from the gold-standard Simcyp Simulator, Simcyp Discovery advances and accelerates small molecule discovery and development. charge point news Find real-time CERT - Certara Inc stock quotes, company profile, news and forecasts from CNN Business.Dec 1, 2023 · 8 brokerages have issued 1 year price objectives for Certara's stock. Their CERT share price targets range from $16.00 to $24.00. On average, they expect the company's share price to reach $19.71 in the next twelve months. This suggests a possible upside of 31.7% from the stock's current price. Certara sold 4,500,000 shares of its common stock, and certain selling stockholders sold 18,500,000 shares of common stock in the offering. The gross proceeds to Certara from the offering were approximately $139.5 million, before deducting the underwriting discount and offering expenses.